Wesana Health to Acquire Psychedelic Therapy and Software Company PsyTech
Business, Research, TreatmentThe deal creates Wesana Clinics, a chain of mental health facilities focused on delivering psychedelic-assisted psychiatric care, as well as data platform Wesana Solutions.
Why Psychedelics Could Eventually Treat Asthma
Research, TreatmentResearchers continue to explore anti-inflammatory nature of psychedelics, which in small doses, may alleviate asthma symptoms.
New Zealand Psychologist Assembles First Study Microdosing Cancer Patients with LSD
Microdosing, ResearchUniversity of Auckland researcher hopes the psychedelic treatment will enhance the effect of psychotherapy, easing end-of-life distress in patients.
Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment
Business, Research, TreatmentCybin CEO says agreement "serves as a major step toward establishing a national distribution network for future psychedelic therapies."
Single Dose of Psilocybin Strengthens Brain Connections in Mice, According to Yale Study
Research“It was a real surprise to see such enduring changes from just one dose of psilocybin," says senior study author Alex Kwan.
Can Psychedelics Reduce Domestic Violence? New Study Suggests Yes
ResearchAlcohol, methamphetamine and cocaine have been linked to increased aggression in men, but psychedelics appear to have opposite effect.
Harvard Law Launches Psychedelics Regulation Research Project
Policy, ResearchPOPLAR is the first academic initiative focused on psychedelics law and policy.
Predicting Psychedelic Experience Outcomes Through Machine Learning
ResearchNew technology that employs machine learning is helping researchers predict psychedelic experience outcomes.
‘Meaningful’ Mescaline Experience Linked to Improvements in Depression, Anxiety
ResearchSignificant personal experiences on the psychedelic mescaline show great promise in treating anxiety and depression, new research finds.
Queen’s University Launches Psychedelic Research Collaborative
ResearchOntario’s Queen’s University’s is launching a psychedelics research collaborative to serve as a space for innovation, and education.